IDXX
Idexx Laboratories Inc /DeCompany with tickers: IDXX
CIK
874716
CUSIP
45168D104
Shares Outstanding
78,882,997
13F Activity (30d)
829 filings
798 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,140,820,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Cost of Revenue | — | ||||
| Gross Profit | $722,739,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Operating Expenses | $360,153,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Research & Development | $65,788,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $362,586,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $278,446,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $3.50 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $3.47 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |